Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis

Post Graduate Institute of Medical Education and Research, Chandigarh · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
cirrhosis
cirrhotic cardiomyopathy, empagliflozin, cardiometabolic risk factors, cirrhosis, empagliflozin in cirrhosis, carvedilol in cirrhosis, sglt-2 inhibitor, ascites, diastolic heart failure, heart failure with preserved ejection fraction, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1008936
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.